FDA PMA FDA Class 2 Approved 🇺🇸 United States

Catheters, Transluminal Coronary Angioplasty, Percutaneous

PMA: P810046 · Supplement: S203 · Decision Jan 11, 2001
Classifications
1
FEI Numbers
70
Registration Numbers
70

Basic Information

Device Name
Catheters, Transluminal Coronary Angioplasty, Percutaneous
Trade Name
RX CHASSIS I CORONARY DILATATION CATHETER
PMA Number
P810046
Supplement Number
S203
Device Class
FDA Class 2
Product Code
LOX
Generic Name
Catheters, transluminal coronary angioplasty, percutaneous
Regulation Number
870.5100
Medical Specialty
Cardiovascular
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
January 11, 2001
Date Received
October 17, 2000
Supplement Type
Real-Time Process
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR THE RX CHASSIS 1(TM) CORONARY DILATATION CATHETER. THE DEVICE, AS MODIFIED, IS INDICATED FOR A) BALLOON DILATATION OF THE STENOTIC PORTION OF A CORONARY ARTERY OF BYPASS GRAFT STENOSIS FOR THE PURPOSE OF IMPROVING MYOCARDIAL PERFUSION, AND B) BALLOON DILATATION OF A CORONARY ARTERY OCCLUSION FOR THE PURPOSE OF RESTORING CORONARY FLOW IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous